Comment on

• Duloxetine 1 year on: the long-term outcome of a cohort of women prescribed duloxetine.

  Vella M, Duckett J, Basu M. Vella M, et al. Int Urogynecol J Pelvic Floor Dysfunct. 2008 Jul;19(7):961-4. doi: 10.1007/s00192-008-0564-4. Epub 2008 Jan 30. Int Urogynecol J Pelvic Floor Dysfunct. 2008. PMID: 18231697 Clinical Trial.
• Randomized, placebo-controlled trial of the cognitive effect, safety, and tolerability of oral extended-release oxybutynin in cognitively impaired nursing home residents with urge urinary incontinence.

  Lackner TE, Wyman JF, McCarthy TC, Monigold M, Davey C. Lackner TE, et al. J Am Geriatr Soc. 2008 May;56(5):862-70. doi: 10.1111/j.1532-5415.2008.01680.x. Epub 2008 Apr 9. J Am Geriatr Soc. 2008. PMID: 18410326 Clinical Trial.
• The destruction of the lower urinary tract by ketamine abuse: a new syndrome?

  Chu PS, Ma WK, Wong SC, Chu RW, Cheng CH, Wong S, Tse JM, Lau FL, Yiu MK, Man CW. Chu PS, et al. BJU Int. 2008 Dec;102(11):1616-22. doi: 10.1111/j.1464-410X.2008.07920.x. Epub 2008 Aug 1. BJU Int. 2008. PMID: 18680495
• Recommendations on the use of botulinum toxin in the treatment of lower urinary tract disorders and pelvic floor dysfunctions: a European consensus report.

  Apostolidis A, Dasgupta P, Denys P, Elneil S, Fowler CJ, Giannantoni A, Karsenty G, Schulte-Baukloh H, Schurch B, Wyndaele JJ; European Consensus Panel. Apostolidis A, et al. Eur Urol. 2009 Jan;55(1):100-19. doi: 10.1016/j.eururo.2008.09.009. Epub 2008 Sep 17. Eur Urol. 2009. PMID: 18823697 Review.
• Practical aspects of lifestyle modifications and behavioural interventions in the treatment of overactive bladder and urgency urinary incontinence.

  Wyman JF, Burgio KL, Newman DK. Wyman JF, et al. Int J Clin Pract. 2009 Aug;63(8):1177-91. doi: 10.1111/j.1742-1241.2009.02078.x. Epub 2009 Jul 2. Int J Clin Pract. 2009. PMID: 19575724 Free PMC article. Review.